Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
DiaMedica Therapeutics Inc. | Chief Medical Officer | Stock option (right to buy) | 285K | Jan 22, 2024 | Direct | ||
DiaMedica Therapeutics Inc. | Chief Medical Officer | Voting Common Shares, no par value per share | 0 | $2.80 | Jan 22, 2024 | Direct | |
OPIANT PHARMACEUTICALS, INC. | Director | Common Stock | 0 | $20.00 | Mar 2, 2023 | Direct | |
OPIANT PHARMACEUTICALS, INC. | Director | Stock Option (right to buy) | 0 | $10.00 | Mar 2, 2023 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
DMAC | DiaMedica Therapeutics Inc. | Jan 22, 2024 | 1 | $0 | 4 | Jan 23, 2024 | Chief Medical Officer |
DMAC | DiaMedica Therapeutics Inc. | Jan 22, 2024 | 0 | $0 | 3 | Jan 23, 2024 | Chief Medical Officer |
OPNT | OPIANT PHARMACEUTICALS, INC. | Mar 2, 2023 | 3 | -$80K | 4 | Mar 3, 2023 | Director |
OPNT | OPIANT PHARMACEUTICALS, INC. | Jun 14, 2022 | 1 | $0 | 4 | Jun 14, 2022 | Director |
OPNT | OPIANT PHARMACEUTICALS, INC. | Jun 15, 2021 | 1 | $0 | 4 | Jun 16, 2021 | Director |